Pharma's new aims explain reform support

Why is Big Pharma such a willing supporter of healthcare reform? The industry has transformed from a business aiming to sell pills to the masses to one that markets very expensive treatments to small groups of sick people--and that changes everything, Forbes' Matthew Herper contends. Report

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.